1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters by Code

Showing 1,267 results.

Thumbnail for Safety and Feasibility of the CALGB 10403 Pediatric-Inspired Regimen in Adults With Acute Lymphoblastic Leukemia Older Than 40 Years

ALL - 588

Safety and Feasibility of the CALGB 10403 Pediatric-Inspired Regimen in Adults With Acute Lymphoblastic Leukemia Older Than 40 Years

Manuel Alejandro Cruz-Martinez

Poster Presenter: Manuel Alejandro Cruz-Martinez

Thumbnail for Olverembatinib Combined With Blinatumomab in Patients With Lymphoid Blast Phase Chronic Myeloid Leukemia (CML-LBP) or Philadelphia Chromosome e-Positive B-Cell Precursor Acute Lymphoblastic Leukemia (Ph+ BCP-ALL)

ALL - 589

Olverembatinib Combined With Blinatumomab in Patients With Lymphoid Blast Phase Chronic Myeloid Leukemia (CML-LBP) or Philadelphia Chromosome e-Positive B-Cell Precursor Acute Lymphoblastic Leukemia (Ph+ BCP-ALL)

Elias Jabbour

Poster Presenter: Elias Jabbour

ABCL - 590

Navigating the WHO-HEAM5 Lymphoma Landscape: An Imaging Primer for Hematologists

Ahmed Salem

Poster Presenter: Ahmed Salem

Thumbnail for Acute Organ Dysfunction Burden as a Predictor of In-Hospital Mortality in Leukemia Hospitalizations: A National Inpatient Sample Analysis (2018-2023)

AML - 591

Acute Organ Dysfunction Burden as a Predictor of In-Hospital Mortality in Leukemia Hospitalizations: A National Inpatient Sample Analysis (2018-2023)

Ramsha Khan

Poster Presenter: Ramsha Khan

Thumbnail for Clinical Predictors of In-Hospital Mortality Among Patients Hospitalized With Acute Myeloid Leukemia: A National Inpatient Sample Analysis (2018-2023)

AML - 592

Clinical Predictors of In-Hospital Mortality Among Patients Hospitalized With Acute Myeloid Leukemia: A National Inpatient Sample Analysis (2018-2023)

Ramsha Khan

Poster Presenter: Ramsha Khan

$Thumbnail for Phase 3, Randomized Study of Talquetamab (Tal) Plus Daratumumab (Dara) ± Pomalidomide (Pom) vs Dara Plus Pom and Dexamethasone (DPd) in Relapsed/Refractory Multiple Myeloma (RRMM): MonumenTAL-3$

MM - 593

Phase 3, Randomized Study of Talquetamab (Tal) Plus Daratumumab (Dara) ± Pomalidomide (Pom) vs Dara Plus Pom and Dexamethasone (DPd) in Relapsed/Refractory Multiple Myeloma (RRMM): MonumenTAL-3

Omik Patel

Poster Presenter: Omik Patel

Thumbnail for Clinical Overview of Infection Events With Orca-T vs Conventional Allogeneic Hematopoietic Stem Cell Transplantation in the Precision-T Phase 3 Study

CT - 594

Clinical Overview of Infection Events With Orca-T vs Conventional Allogeneic Hematopoietic Stem Cell Transplantation in the Precision-T Phase 3 Study

Roni Tamari

Poster Presenter: Roni Tamari

Thumbnail for Predictors of In-Hospital Mortality Among Patients Hospitalized With Chronic Myeloid Leukemia: A National Inpatient Sample Analysis (2018-2023)

CML - 596

Predictors of In-Hospital Mortality Among Patients Hospitalized With Chronic Myeloid Leukemia: A National Inpatient Sample Analysis (2018-2023)

Ramsha Khan

Poster Presenter: Ramsha Khan

Thumbnail for Updated Results of POLARIS-1 (Part 1), a Global Registrational Phase 3 Study: Olverembatinib Combined With Low-Intensity Chemotherapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

ALL - 597

Updated Results of POLARIS-1 (Part 1), a Global Registrational Phase 3 Study: Olverembatinib Combined With Low-Intensity Chemotherapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Suning Chen

Poster Presenter: Suning Chen